US EditionMedicare Cuts Prices 36% on 15 Costly Drugs | Honolulu Star-Advertiser
3 Articles
3 Articles
Medicare cuts prices 36% on 15 costly drugs | Honolulu Star-Advertiser
The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs.
Pharmalittle: We’re reading about Medicare-negotiated drug prices, an FDA voucher program, and more
Happy Thanksgiving Eve, Pharmalittle readers. This is Allison, filling in for Mr. Pharmalot. I recently hosted a mini Thanksgiving dinner for friends, and was stumped trying to pick music to play in the background. Why aren’t there any real Thanksgiving songs? We have an overabundance of Christmas music. I certainly can’t play Adam Sandler’s Thanksgiving song over and over all night. Please reach out if you have any music suggestions! This newsl…
The U.S. health program Medicare said Tuesday that the new prices negotiated for 15 of its most expensive drugs will save 36% on those drugs compared to recent annual spending, that is, about $8.5 billion in net prescription costs covered. Prices will come into effect in 2027, including a monthly price of $274 for Novo Nordisk’s popular GLP-1 semaglutide drug, sold as Wegovy for weight loss and Ozempic for diabetes.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
